Page 6 - ஹிசாமிட்சு மருந்து இணை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹிசாமிட்சு மருந்து இணை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹிசாமிட்சு மருந்து இணை இன்க் Today - Breaking & Trending Today

Cold Pain Therapy Market to Grow at a CAGR of 4.6% During the Forecast Period 2020–2025


(+1) 614-588-8538
Cold Pain Therapy Market to Grow at a CAGR of 4.6% During the Forecast Period 2020–2025
Increasing Number of Traumatic Injuries Resulting From Falls, Mishaps, and Road Accidents are Contributing to the Growth of Cold Pain Therapy Market.
BriefingWire.com, 1/14/2021 - Cold Pain Therapy Market size in 2019 is estimated to be $ 1,690 million, growing at a CAGR of 4.6% during the forecast period 2020-2025. The cold pain therapy includes the usage of cold materials to relieve pain. Cryotherapy is used for injury management and it reduces the blood circulation, thereby reducing inflammation, muscle spasm and pain. Increasing incidence of injury caused during sports activities and rising geriatric population are the major factors driving the growth of the market. ....

United States , Venkat Reddy , Performance Health , Centers For Disease , Hisamitsu Pharmaceutical Co Inc , Pacira Biosciences Inc , Our Custom Research Services , Romsons Group Of Industries , Breg Inc , Pfizer Inc , American Academy Of Orthopedic Surgeons , Deroyal Industries Inc , Pain Therapy Market , Forecast Period , Traumatic Injuries Resulting From Falls , Road Accidents , Cold Pain Therapy , North America , Cold Pain Therapy Market , Pain Therapy Market Segment Analysis , Disease Control , American Academy , Orthopedic Surgeons , Asia Pacific , During Sports , Deroyal Industries ,

Basic Agreement Reached with All 68 Tokyo 2020 Domestic Partners regarding Contract Extension


Basic Agreement Reached with All 68 Tokyo 2020 Domestic Partners regarding Contract Extension
12/24/20
Tokyo, 24 December 2020 - The Tokyo Organising Committee of the Olympic and Paralympic Games (Tokyo 2020) today announced that, with regard to the hosting of the Tokyo 2020 Games next year, it has reached basic agreement with all 68 Tokyo 2020 domestic partner companies on an extension of their sponsorship contracts. Based on this agreement, we are proceeding with the conclusion of contracts with all partners.
Tokyo 2020 President MORI Yoshiro commented as follows:
We have recently confirmed that we have reached basic agreement with all domestic partners supporting the Tokyo 2020 Games regarding the extension of their contracts into 2021. ....

United States , Yomiuri Shimbun , Tokyo Gas Co Ltd , Holdings Inc , Canon Inc , Telephone Corporation , Morisawa Inc , Yahoo Japan Corporation , Tokyo Metro Co Ltd , Japan Post Holdings , East Japan Railway Company , Japan Airport Terminal Co Ltd , Japan Airlines Co Ltd , Ottobock Se Co , Marketing Programme , Earth Corporation , Kikkoman Corporation , Tokio Marine Nichido Fire Insurance Co Ltd , Holdings Co Ltd , Procter Gamble , Ey Japan Co Ltd , Dai Nippon Printing Co Ltd , Ef Education First Japan Ltd , Japan Railway Company , Hokkaido Shimbun , Ajinomoto Co Inc ,

Results from Pivotal, Phase 3 Trial for SECUADO® (asenapine) Published in Journal of Clinical Psychiatry


Share:
First and Only FDA Approved Transdermal System Now Available to Nearly 220 Million Insured Adults Living with Schizophrenia in the U.S.
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced publication of the results from a pivotal, phase 3 trial, which showed that SECUADO
® (asenapine) transdermal system demonstrated significant improvement in Positive and Negative Syndrome Scale (PANSS) total score at Week 6 versus placebo in adult patients with schizophrenia. SECUADO is the first-and-only transdermal patch formulation for the treatment of adults with schizophrenia approved by the U.S. Food and Drug Administration.
1 The data are published in the January/February 2021 edition of the ....

United States , Leslie Citrome , Joel Lippman , Hisamitsu Pharmaceutical Co Inc , Noven Therapeutics , Drug Administration , York Medical College , National Institute Of Mental Health , National Pregnancy Registry For Atypical Antipsychotics , Noven Care Access Network , Behavioral Sciences , Noven Pharmaceuticals Inc , Transdermal System Now Available , Insured Adults Living , Negative Syndrome Scale , Clinical Professor , New York Medical , Chief Operating Officer , Chief Medical Officer , Noven Pharmaceuticals , Prescribing Information , Malignant Syndrome , National Pregnancy Registry , Noven Care Access , Asenapine Transdermal System , Patients With ,